Loading

DermaXon LLC

June 05, 2024
Company Presentation
Dermatology
Company Presentation Theater 3
DermaXon is a drug discovery and development company providing first in-class drug candidates. DermaXon works to discover and develop novel therapeutic strategies to treat and prevent life-threatening skin diseases and disorders. The company was founded in 2013 by Dr. Philippe Diaz Professor at the Department of Biomedical Sciences at the University of Montana. The company core technology is based on the design and development of small molecules and proteolysis targeting chimera (PROTAC) modulating understudied targets. DermaXon uses medicinal chemistry, molecular biology, artificial intelligence and machine learning, and RNA sequencing to characterize and identify synergies and overlaps between biological signaling pathways modulated by these molecules and triggering the initiation of diseases and disorders.
DermaXon LLC
Company Website: http://dermaxon.com
Lead Product in Development: DX308
Number Of Unlicensed Products (For Which You Are Seeking Partners): 2

Company HQ City

Missoula

Company HQ State

MT

Company HQ Country

United States

CEO/Top Company Official

Philippe Diaz

Development Phase of Primary Product

Pre-Clinical
Speakers
Philippe Diaz
CEO
Dermaxon Llc
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS